Consistent with this, the suppression of GATA3 has been shown to improve the adipogenesis process, restore insulin sensitivity, and reduce obesity-associated inflammation in patients with obesity (57). Here, GATA3 is linked to obesity due to melanocortin 4 receptor deficiency.